TRAX • NASDAQ
First Tracks Biotherapeutics Inc
$32.40
Stock Details
| Market Cap | 1,130,513,144 |
|---|---|
| Day Change | 11.63 (55.99%) |
| Volume | 4,474,140 |
| Avg Volume | 528,242 |
| Price Range | 14.72-33.7 |
Overview
| Country | US |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
Company Profile
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Financial Overview
| 52 Week High | 33.7 |
|---|---|
| 52 Week High Date | 2026-07-09 |
| 52 Week Low | 14.72 |
| 52 Week Low Date | 2026-06-03 |
| 10D Avg Trading Vol | 1.07751 |
| YTD Price Return Daily | 70.5263 |
| MTD Price Return Daily | 61.0338 |
Cash Flow
| TTM/Share | |
|---|---|
| Annual/Share | -4.1156 |
| Quarterly/Share |
Price-to-Earnings
| Annual Ratio | 10.1989 |
|---|---|
| Quarterly Ratio | 8.7401 |
| TTM |
Earnings Per Share
| Annual | -4.7796 |
|---|---|
| 3Y Growth | |
| 5Y Growth | |
| Quarterly YOY Growth |
Price-to-Book
| Ratio | 4.391 |
|---|---|
| Annual Ratio | |
| TTM |